-

SpineGuard: The PediGuard® Device Was Featured in an Article Marking the 100th Anniversary of SOFCOT

PediGuard® recognized as one of the major innovations in Spinal Surgery in France

PARIS--(BUSINESS WIRE)--Regulatory News:

SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces the publication of an article on French innovations as part of the 100th anniversary of SOFCOT (French Society of Orthopedic and Traumatological Surgery), which recently held its annual conference in Cannes (France). This review aims to highlight the French innovations that have profoundly shaped the evolution of spinal surgery in France and identifies PediGuard® as one of them.

Patricia Lempereur, Vice President of Sales and Marketing, said: “We are particularly proud that the PediGuard® is mentioned in this article as ‘a French innovation supporting spinal surgical safety.’ Its reliability and utility are highlighted, as well as its clinical recognition through numerous scientific articles.”

Since its introduction to the market, more than 120,000 spinal surgeries have been performed safely using DSG® technology, and nearly 50 scientific publications have highlighted its benefits across various indications and recognized it as a benchmark for ensuring accurate pedicle drilling. They were conducted by surgeons and research teams from many countries and are the result of laboratory studies, preclinical studies, clinical studies (including randomized controlled trials), systematic reviews, and meta-analyses. Taken together, these publications have demonstrated the reliability of DSG® technology, its precision, and its ability to reduce radiation exposure or shorten operating time during the placement of pedicle screws in all types of adult and pediatric spinal surgery, whether performed via open or minimally invasive approaches. Some of these publications focus on new applications of DSG® technology, particularly in robotics.

This growing body of published research forms the foundation of the credibility of DSG® technology, which SpineGuard is building in collaboration with renowned surgeons and its partners.

About SpineGuard®

Founded in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard is an innovative company deploying its proprietary radiation-free real time sensing technology DSG® (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. SpineGuard designs, develops and markets medical devices embedding its technology. Over 120,000 surgical procedures have been secured worldwide thanks to DSG® and 49 studies published in peer-reviewed scientific journals have demonstrated the multiple benefits DSG® offers to patients, surgeons, surgical staff and hospitals. Building on these strong fundamentals and several strategic partnerships, SpineGuard is expanding the scope of its DSG® technology to the treatment of scoliosis via anterior approach, sacroiliac joint fusion, dental implantology and innovations such as the « smart » pedicle screw and power drill or surgical robotics. DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer. SpineGuard has engaged in multiple ESG initiatives. For further information, visit www.spineguard.com.

Disclaimer

The SpineGuard securities may not be offered or sold in the United States as they have not been and will not be registered under the Securities Act or any United States state securities laws, and SpineGuard does not intend to make a public offer of its securities in the United States. This is an announcement and not a prospectus, and the information contained herein does and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in the United States in which such offer, solicitation or sale would be unlawful prior to registration or exemption from registration.

Contacts

SpineGuard
Pierre Jérôme
CEO & Chairman
Tel. : 01 45 18 45 19
p.jerome@spineguard.com

SpineGuard
Anne-Charlotte Millard
CFO
Tel. : 01 45 18 45 19
ac.millard@spineguard.com

NewCap
Investor Relations & Financial Communication
Mathilde Bohin
Tel. : 01 44 71 94 94
spineguard@newcap.eu

SpineGuard

BOURSE:ALSGD

Release Versions

Contacts

SpineGuard
Pierre Jérôme
CEO & Chairman
Tel. : 01 45 18 45 19
p.jerome@spineguard.com

SpineGuard
Anne-Charlotte Millard
CFO
Tel. : 01 45 18 45 19
ac.millard@spineguard.com

NewCap
Investor Relations & Financial Communication
Mathilde Bohin
Tel. : 01 44 71 94 94
spineguard@newcap.eu

More News From SpineGuard

SpineGuard Announces Its Q3 Revenue

PARIS--(BUSINESS WIRE)--Regulatory News: SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces its third quarter 2026 revenue. Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated: “The third quarter marks an important milestone for SpineGuard with a +22% increase in the number of units sold worldwide, driven by strong m...

SpineGuard Reports 2026 Half-Year Results

PARIS--(BUSINESS WIRE)--Regulatory News: SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces its financial results for the first half of the fiscal year ended June 30, 2026, as approved by the Board of Directors held on September 9, 2026. Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated: “Our half-year financial re...

SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory

PARIS--(BUSINESS WIRE)--Regulatory News: SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology—which measures the electrical conductivity of tissues locally in real time—to ensure the safe and simplified placement of bone implants, announced today that it has been granted a new U.S. patent by the USPTO (U.S. Patent and Trademark Office) for a robotically assisted ultrasound technology designed to determine the entry point and pedic...
Back to Newsroom